T4P 1001

Drug Profile

T4P 1001

Alternative Names: T4P1001

Latest Information Update: 08 Dec 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Tools4Patient
  • Class Analgesics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Neuropathic pain; Pain

Most Recent Events

  • 05 Oct 2017 Tools4Patient completes a phase II trial for Osteoarthritic Pain and Neuropathic pain in France and Belgium (PO) (NCT02989792)
  • 08 Feb 2017 Tools4Patient initiates enrolment in a phase II trial for Osteoarthritic Pain and Neuropathic pain in France and Belgium (PO) (NCT02989792)
  • 08 Dec 2016 Tools4Patients plans a clinical trial for Neuropathic pain and Osteoarthritic pain in France and Belgium (PO) (NCT02989792)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top